XML 57 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1
Revenue Recognition (Tables)
 12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by line of business and product type (in thousands):
For the Year Ended December 31,
202420232022
Medicaid$862,401 $785,053 $559,362 
Medicare1,045,921 708,853 458,413 
Commercial and other646,419 469,990 334,238 
Total$2,554,741 $1,963,896 $1,352,013 
Performance Suite$1,801,879 $1,214,661 $808,642 
Specialty Technology and Services Suite338,306 296,366 51,898 
Administrative Services238,036 296,244 407,523 
Cases176,520 156,625 83,950 
Total$2,554,741 $1,963,896 $1,352,013 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of December 31, 2024 and 2023 (in thousands):
December 31,
20242023
Short-term receivables (1)
$413,346 $446,220 
Short-term deferred revenue2,507 5,976 
Long-term deferred revenue— 1,173 
————————
(1)Excludes pharmacy rebate receivable and pharmacy claims receivable.

Changes in deferred revenue for the year ended December 31, 2024 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$7,149 
Reclassification to revenue, as a result of performance obligations satisfied(5,672)
Cash received in advance of satisfaction of performance obligations1,030 
Balance as of end of period$2,507